Reproductive Health & Justice FOIA Request Seeks Comprehensive Safety Data on Mifepristone from FDA April 24, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been formally submitted to the U.S. Food and Drug Administration (FDA), seeking a broad spectrum of safety data pertaining to mifepristone, a…
Reproductive Health & Justice FOIA Request Filed for Comprehensive Mifepristone Safety Data Amid Evolving Regulatory Scrutiny April 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on March 20, 2026, seeking a broad spectrum of safety data related to mifepristone, a medication widely used in medication abortion…
Reproductive Health & Justice FOIA Request Seeks Deeper Dive into Mifepristone Safety Data from FDA April 9, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been submitted to the U.S. Food and Drug Administration (FDA) seeking comprehensive safety data related to mifepristone, a medication used in medication…
Reproductive Health & Justice FDA Adverse Event Data FOIA April 1, 2026 Rifan Muazin The submission of a Freedom of Information Act (FOIA) request on March 20, 2026, seeking comprehensive safety data on mifepristone, marks a significant development in the ongoing scrutiny of this…
Reproductive Health & Justice FDA Adverse Event Data FOIA March 25, 2026 Rifan Muazin Advocacy Group Demands FDA Transparency on Mifepristone Safety Data Amidst Ongoing Legal Battles A prominent reproductive rights advocacy organization has formally requested detailed safety data pertaining to mifepristone, a medication…
